Hsp65 Protein and Its Role in Murine Lupus
Author Information
Author(s): Marengo Eliana B., de Moraes Luciana V., Faria Marcella, Fernandes Beatriz L., Carvalho Luciana V., Tambourgi Denise V., Rizzo Luiz V., Portaro Fernanda C. V., Camargo Antônio Carlos M., Sant'Anna Osvaldo A.
Primary Institution: Instituto Butantan, São Paulo, Brazil
Hypothesis
The study evaluates the pathophysiological role of the wild type and mutated Hsp65 of M. leprae in an animal model of Systemic Lupus Erythematosus.
Conclusion
Hsp65 may accelerate the progression of lupus in treated mice, while the mutated K409A form may mitigate its effects.
Supporting Evidence
- WT Hsp65 treatment significantly shortened the mean survival time of treated mice.
- K409A-treated mice showed no significant increase in anti-DNA antibody levels compared to untreated mice.
- Environmental factors significantly influenced the progression of SLE in the study.
Takeaway
This study shows that a protein from bacteria can make mice with lupus get worse faster, but a small change in that protein can help them feel better.
Methodology
The study involved injecting mice with either wild type or mutated Hsp65 and monitoring their survival and immune response.
Limitations
The study is limited to a specific mouse model and may not fully represent human lupus.
Participant Demographics
Female NZBxNZW F1 mice were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website